The $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients | Fortune

More than 5,000 shelved drug candidates were discontinued for business reasons, not safety ones. A new push aims to match them with the highest need.

Raccontata dafortune.com